Cargando…

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome

BACKGROUND: Clinical outcome of patients with high-risk melanoma cannot be reliably predicted on the basis of classical histopathological examination. Our study aimed to determine in melanoma metastases a gene expression profile associated with patient survival, and to identify and validate marker(s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Journe, F, Boufker, H Id, Van Kempen, L, Galibert, M-D, Wiedig, M, Salès, F, Theunis, A, Nonclercq, D, Frau, A, Laurent, G, Awada, A, Ghanem, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242608/ https://www.ncbi.nlm.nih.gov/pubmed/22045183 http://dx.doi.org/10.1038/bjc.2011.451

Ejemplares similares

SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma
por: El Hajj, P, et al.
Publicado: (2015)

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients
por: El Hajj, P, et al.
Publicado: (2013)

Increased Dickkopf-1 expression in breast cancer bone metastases
por: Voorzanger-Rousselot, N, et al.
Publicado: (2007)

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
por: Id Boufker, Hichame, et al.
Publicado: (2010)

mRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
por: Baren, J P, et al.
Publicado: (2012)

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
por: Loupakis, F, et al.
Publicado: (2013)

Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes
por: Thomson, A H, et al.
Publicado: (2016)

Genomic instability and proliferative activity as risk factors for distant metastases in breast cancer
por: Li, L, et al.
Publicado: (2008)

Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value
por: Evert, M, et al.
Publicado: (2013)

Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases
por: Mole, D J, et al.
Publicado: (2011)

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer
por: Van den Eynden, G G, et al.
Publicado: (2006)

Myofibroblast activation in colorectal cancer lymph node metastases
por: Yeung, T M, et al.
Publicado: (2013)

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
por: Kalikaki, A, et al.
Publicado: (2008)

Nucleostemin mRNA is expressed in both normal and malignant renal tissues
por: Fan, Y, et al.
Publicado: (2006)

The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases
por: Rajaganeshan, R, et al.
Publicado: (2007)

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma
por: Bonvini, P, et al.
Publicado: (2013)

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
por: Goebel, G, et al.
Publicado: (2012)

Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases
por: Kahlert, C, et al.
Publicado: (2014)

Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases
por: Bouchard, G, et al.
Publicado: (2013)

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
por: de la Piedra, C, et al.
Publicado: (2013)

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer
por: Ohlsson, L, et al.
Publicado: (2012)

Low expression of γ-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype
por: Kawakami, K, et al.
Publicado: (2008)

Migration rules: tumours are conglomerates of self-metastases
por: Enderling, H, et al.
Publicado: (2009)

Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
por: Lee, G T, et al.
Publicado: (2014)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
por: Zlobec, I, et al.
Publicado: (2014)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases
por: Buckowitz, A, et al.
Publicado: (2005)

Mechanisms of local immunosuppression in cutaneous melanoma
por: Polak, M E, et al.
Publicado: (2007)

Cytokine Landscape in Central Nervous System Metastases
por: Marin, Julie, et al.
Publicado: (2022)

Nuclear ING2 expression is reduced in human cutaneous melanomas
por: Lu, F, et al.
Publicado: (2006)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015)

Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
por: Deans, D A C, et al.
Publicado: (2006)

KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
por: Basso, M, et al.
Publicado: (2013)

Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases
por: Dzieȩgiel, P, et al.
Publicado: (2010)

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
por: Knijn, N, et al.
Publicado: (2011)

Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer
por: Solassol, J, et al.
Publicado: (2010)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
por: Alcaraz, A, et al.
Publicado: (2013)

Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer
por: Hamaya, Y, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k5dfbi1c67q3pfo4983ai0iub2